These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2877341)

  • 1. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 2. Complication of triptorelin treatment for uterine myomas.
    Ellenbogen A; Shulman A; Libal Y; Jaschevatzky O; Anderman S; Grunstein S
    Lancet; 1989 Jul; 2(8655):167-8. PubMed ID: 2567943
    [No Abstract]   [Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
    Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
    Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
    [No Abstract]   [Full Text] [Related]  

  • 4. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
    van Leusden HA; Dogterom AA
    Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F; Repinto A; Andreoli C
    Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
    George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV
    Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
    Friedman AJ
    Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot GnRH analog treatment of uterine fibroids.
    Loverro G; Nicolardi V; Selvaggi L
    Int J Gynaecol Obstet; 1993 Nov; 43(2):199-201. PubMed ID: 7905441
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels.
    Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E
    Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
    Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
    Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of LHRH analogue action in uterine fibroids.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GnRH analogues and myomas: somewhat for].
    Bats AS; Madelenat P
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1023-7. PubMed ID: 16316773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.